Xenon Pharmaceuticals (XENE) is undervalued given azetukalner's late-stage potential to transform epilepsy and mood disorder ...
Smith's comments come just weeks after Saskatchewan-based potash giant Nutrien announced plans to build a $1-billion export ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback